Sustained-Release Anesthetic Composition via Lyophilized Lipid Structure

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preparing sustained-release local anesthetics often result in low drug entrapment efficiency and involve complex, costly manufacturing processes.

Innovation Solution

A one-step lyophilization method is used to create a highly entrapped lipid structure (HELS) comprising a local anesthetic and a lipid mixture, which is then hydrated with a pH-controlled buffer to form multilamellar vesicles (MLVs) with entrapped anesthetic.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional multilamellar liposomal local anesthetics are prepared using dehydration-rehydration method, then sustained-release effect is achieved, but drug entrapment efficiency is low and manufacturing process is complex

Engineering Contradiction:
Improvesustained-release effectVSAvoidmanufacturing process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent changes the preparation method from traditional dehydration-rehydration to a modified thin-film hydration method using ammonium sulfate gradient. This parameter change in the preparation process achieves high drug entrapment efficiency (greater than 60%) while maintaining the sustained-release effect, thereby resolving the contradiction between reliability and manufacturing complexity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent forms a thin lipid film beforehand and then hydrates it with ammonium sulfate solution to create the gradient. This preliminary formation of the lipid film structure allows for efficient drug entrapment during subsequent hydration, avoiding the need for complex multistep dehydration-rehydration cycles while achieving sustained-release

Inventive Principle:
Principle #10Preliminary action

2Reliability

If giant multivesicular liposomal local anesthetics are prepared using ammonium sulfate gradient loading, then drug entrapment efficiency is improved, but manufacturing process becomes more complex and costly

Engineering Contradiction:
Improvedrug entrapment efficiencyVSAvoidmanufacturing process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent merges the advantages of both traditional MLV preparation and GMV gradient loading into a single streamlined process. By combining thin-film formation with ammonium sulfate gradient hydration in one sequence, the method achieves high drug entrapment efficiency without requiring separate complex gradient loading steps, thus resolving the contradiction between entrapment efficiency and manufacturing complexity

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent extracts and eliminates the complex multiple dehydration-rehydration cycles and separate gradient loading steps from the traditional process. By taking out these unnecessary intermediate steps and using a single hydration step with ammonium sulfate gradient, the method achieves high drug entrapment while simplifying the manufacturing process

Inventive Principle:
Principle #2Taking out (Extraction)

3Duration of action of stationary object

If multiple dehydration-rehydration cycles are performed to form multilamellar vesicles, then sustained-release duration is extended, but production time and cost increase

Engineering Contradiction:
Improveduration of anesthesiaVSAvoidproduction time
Core Design Contradiction:
Duration of action of stationary objectVSLoss of time

Solution Approach 1:

The patent performs preliminary formation of the thin lipid film structure before hydration, which pre-organizes the lipid molecules into a configuration that spontaneously forms multilamellar vesicles upon single hydration. This preliminary structuring eliminates the need for multiple repeated dehydration-rehydration cycles, thereby extending anesthesia duration while reducing production time

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent utilizes the phase transition of water into the lipid film during hydration to spontaneously form multilamellar vesicles. The ammonium sulfate gradient drives water into the film, causing it to fold and form sustained-release structures in one step, replacing multiple cyclic phase transitions with a single efficient transition that reduces production time while maintaining extended duration of action

Inventive Principle:
Principle #36Phase transitions

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach achieves a rapid onset of anesthesia with a prolonged duration of local anesthesia and minimal toxicity, while also simplifying the manufacturing process and reducing production costs.

Implementation Method 1

A one-step lyophilization method is used to create a highly entrapped lipid structure (HELS)

Methodology Applied
Scientific EffectLyophilization: Freeze Drying

Implementation Method 2

hydrated with a pH-controlled buffer to form multilamellar vesicles (MLVs) with entrapped anesthetic

Methodology Applied
Scientific EffectHydration: Mineral Hydration

Data Source

PatentUS12280043B2Sustained-release anesthetic compositions and methods of preparation thereof
Publication Date: 2025.04.22 TLC BIOPHARMACEUTICALS INC
  • US12280043B2 patent drawing
  • US12280043B2 patent drawing
  • US12280043B2 patent drawing

AI summary

Provided is an anesthetic composition for locally administrating an amide-type anesthetic into a subject in need thereof. The anesthetic composition has multilamellar vesicles with entrapped amide-type anesthetic prepared by hydrating a highly entrapped lipid structure comprising an amide-type anesthetic and a lipid mixture with an aqueous buffer solution at a pH higher than 5.5. Also provided is a method to prepare an anesthetic composition using a simpler and more feasible process for large-scale manufacture and for providing a high molar ratio of amide-type anesthetic to phospholipid content as compared to the prior art. This anesthetic composition has a prolonged duration of efficacy adapted to drug delivery.